Clinical trial
Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or…
NCT00136084 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00136084 |
|---|---|
| Title | Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia |
| Official title | A Collaborative Trial for the Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Myelocytic, Acute |
| Intervention type | Drug |
| Interventions | Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone, Etoposide, Gemtuzumab, L-asparaginase, Mercaptopurine, methotrexate and 3 more |
| Enrollment | 238 |
| Start date | Aug 1, 2002 |
| Primary completion | Jul 1, 2008 |
| Completion | Jun 1, 2012 |
| First posted | Aug 26, 2005 |
| Last update posted | Dec 5, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: